Relationship between high dose irinotecan (260mg/m2) and response rate, without increased toxicities in metastatic colorectal cancer (MCRC) combination with bi-weekly 5FU/FA in a phase II study

✍ Scribed by Ducreux, M.; Raoul, J.; Merrouche, Y.; Marti, P.; Risse, M.; Mery-mignard, D.; Ferment, O.; Boige, V.

• Book ID: 123433633
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 194 KB
• Volume: 37
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(01)81587-2